DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slipped 1.11% to $149.69 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.02% to 7,704.13 and Dow Jones Industrial Average falling 0.31% to 51,349.98.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 4.83% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.56% to $270.68, Pfizer Inc. $(PFE)$ rose 0.82% to $28.41, and Abbott Laboratories $(ABT)$ fell 2.34% to $101.07.
Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.